COST-UTILITY ANALYSIS OF PNEUMOCOCCAL VACCINES FOR OLDER ADULTS AVAILABLE IN COSTA RICA

被引：0
|
作者：
Ordonez, J. [1 ]
Castro, Baldi J. J. [2 ]
机构：
[1] True Consulting, Medellin, Ant, Colombia
[2] Pfizer Cent Amer & Caribbean, San Jose, Costa Rica
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
HTA31
引用
收藏
页码：S264 / S264
页数：1
相关论文
共 50 条
  • [1] COST-UTILITY ANALYSIS OF PNEUMOCOCCAL VACCINES FOR OLDER ADULTS AVAILABLE IN EL SALVADOR
    Ordonez, J.
    Castro, J. J. Baldi
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S267 - S267
  • [2] BUDGET IMPACT ANALYSIS OF PNEUMOCOCCAL VACCINES FOR OLDER ADULTS AVAILABLE IN COSTA RICA
    Ordonez, J.
    astro, Baldi J. J.
    [J]. VALUE IN HEALTH, 2023, 26 (06) : S77 - S77
  • [3] COST-UTILITY ANALYSIS OF PNEUMOCOCCAL CONJUGATE VACCINES IN GERMANY
    Knoll, S.
    Jochum, D.
    Talbird, S. E.
    [J]. VALUE IN HEALTH, 2009, 12 (07) : A429 - A429
  • [4] Cost-utility analysis of the universal pneumococcal vaccination programme for older adults in Norway
    Nymark, Liv Solvar
    Berild, Jacob Dag
    Lyngstad, Trude Marie
    Winje, Brita Askeland
    Vestrheim, Didrik Frimann
    Aaberge, Ingeborg
    Juvet, Lene Kristine
    Wolff, Ellen
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2022, 18 (06)
  • [5] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH HEART FAILURE IN COSTA RICA
    Ordonez, J.
    Quesada Chaves, D. F.
    Rodriguez, M.
    Poveda, J.
    Speranza, M.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S360 - S360
  • [6] COST-UTILITY ANALYSIS OF BENRALIZUMAB IN SEVERE EOSINOPHILIC ASTHMA IN COSTA RICA
    Ordonez, J.
    Guadamuz, R.
    Monge, O.
    Ordonez, A.
    Hidalgo Godinez, J.
    Buitrago, R.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S382 - S383
  • [7] COST-UTILITY ANALYSIS OF DAPAGLIFLOZIN IN PATIENTS WITH CHRONIC KIDNEY DISEASE IN COSTA RICA
    Ordonez, J.
    Hernandez, F.
    Rodriguez, G.
    Estrada, J.
    Ordonez, A.
    Hidalgo Godinez, J.
    Villalobos, K.
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S403 - S403
  • [8] COST-UTILITY ANALYSIS OF PREVENTIVE HOME VISITS IN OLDER ADULTS
    Brettschneider, C.
    Luck, T.
    Fleischer, S.
    Roling, G.
    Beutner, K.
    Sesselmann, Y.
    Luppa, M.
    Behrens, J.
    Riedel-Heller, S.
    Koenig, H. H.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A511 - A511
  • [9] Towards the introduction of pneumococcal conjugate vaccines in Bhutan: A cost-utility analysis to determine the optimal policy option
    Dorji, Kinley
    Phuntsho, Sonam
    Pempa
    Kumluang, Suthasinee
    Khuntha, Sarayuth
    Kulpeng, Wantanee
    Rajbhandari, Sneha
    Teerawattananon, Yot
    [J]. VACCINE, 2018, 36 (13) : 1757 - 1765
  • [10] Cost-utility analysis of a preventive home visit program for older adults in Germany
    Christian Brettschneider
    Tobias Luck
    Steffen Fleischer
    Gudrun Roling
    Katrin Beutner
    Melanie Luppa
    Johann Behrens
    Steffi G Riedel-Heller
    Hans-Helmut König
    [J]. BMC Health Services Research, 15
12345